Szulc Agata, Czernikiewicz Andrzej
Klinika Psychiatrii AM w Białymstoku.
Psychiatr Pol. 2007 Jan-Feb;41(1):17-27.
The authors review the literature on the topic of early identification and intervention in "pre-psychotic" and "pre-schizophrenic" persons. Most of the early intervention programmes include more or less "false positive results". There is still no classic biological marker of schizophrenia available. Authors review the possible markers of schizophrenia, including some neurophysiological and neurocognitive disorders (eye-tracking dysfunction, sensory motor gating dysfunction, working memory and other neurocognitive dysfunctions) and also structural, neurochemical and functional brain abnormalities. Unfortunately, the marker of transition to psychosis is still unknown. Only the complex analysis of all possible factors: family, social, clinical and biological can be helpful in identification of the future schizophrenic persons. The authors also review the research on the treatment of "pre-psychotic" persons. The most frequent methods used in these cases are the generation antipsychotics in low doses and psychotherapy. The results are promising, but need further confirmation, both in every day practice and in randomized controlled trials.
作者回顾了关于“精神病前期”和“精神分裂症前期”人群早期识别与干预这一主题的文献。大多数早期干预项目或多或少都包含“假阳性结果”。目前仍没有可用的典型精神分裂症生物学标志物。作者回顾了精神分裂症可能的标志物,包括一些神经生理和神经认知障碍(眼动追踪功能障碍、感觉运动门控功能障碍、工作记忆及其他神经认知功能障碍)以及大脑结构、神经化学和功能异常。不幸的是,向精神病转变的标志物仍然未知。只有对所有可能因素:家庭、社会、临床和生物学因素进行综合分析,才有助于识别未来的精神分裂症患者。作者还回顾了关于“精神病前期”人群治疗的研究。这些病例中最常用的方法是低剂量的新一代抗精神病药物和心理治疗。结果很有前景,但无论是在日常实践还是随机对照试验中都需要进一步证实。